Rocket Lab Corporation (NASDAQ:RKLB), the maker of reusable Electron rockets and the upcoming Neutron launch vehicle, is drawing fresh attention after agreeing to buy satellite communications operator Iridium (NASDAQ:IRDM) for roughly 8 billion dollars in a cash and stock deal expected to close by mid 2027.
| Price | 100.46 USD |
|---|---|
| Day change | +0.39 (+0.39%) |
| 52-week range | 73.99 – 151.0 |
| Market cap | $62.77B |
| P/E ratio | -313.94 |
| EPS (ttm) | -0.32 |
| RSI (14) | 48.01 |
| Volume | 22,233,599 |
A Bet on Steadier Cash Flow
Rocket Lab shares traded at 100.46 dollars, up 0.39% on the day, giving the company a market cap of 62.77 billion dollars. The stock still sits well below its 52 week high of 151.00 and comfortably above its low of 73.99, a range that reflects just how volatile sentiment around space stocks has been over the past year.
The Iridium acquisition would hand Rocket Lab a business built on recurring subscription revenue rather than one time launch contracts. Iridium counts more than 2.5 million subscribers, operates its own satellite constellation, and holds weather resilient L band spectrum along with a consumer facing data network. For a company whose core launch and satellite component businesses are capital intensive and thin margined, that kind of steady cash generation could be a meaningful counterweight.
Why Margins Matter Right Now
Rocket Lab's income statement tells the story of a company still investing heavily ahead of profitability. Its price to earnings ratio sits at negative 313.94, and earnings per share remain negative, a familiar pattern for a firm plowing capital into Neutron development and expanded satellite manufacturing. There is no dividend to speak of, so investors are being asked to weigh growth potential against a business that hasn't yet turned a sustained profit.
The competitive backdrop adds urgency. SpaceX's Starship, once operational at scale, threatens to push launch costs down sharply, squeezing exactly the kind of margins Rocket Lab earns today from Electron missions. Diversifying into Iridium's subscription model gives Rocket Lab a hedge against that pricing pressure and a path toward controlling more of the space economy stack: manufacturing, launch, spectrum, and orbital operations, an arrangement that currently only SpaceX itself can claim.
Valuation, Momentum and Yield at Rocket Lab
Rocket Lab's relative strength index reads 48.01, a neutral level that suggests the stock is neither overbought nor oversold as traders digest the Iridium news. There's no dividend yield to factor in, so any case for owning shares rests entirely on future growth rather than income.
The bull case centers on scale and diversification: a combined Rocket Lab and Iridium would generate higher margin, recurring revenue while also fielding a satellite fleet and spectrum assets that few competitors can match outside of SpaceX. Bears point to the negative P/E ratio, the size of the deal relative to Rocket Lab's market cap, and the execution risk of integrating a legacy satellite operator while still developing Neutron. Regulatory review and shareholder approval also stand between announcement and the targeted mid 2027 close.
What Happens Between Now and Mid 2027
Until the deal closes, Rocket Lab continues operating as two separate stories: a launch and satellite component business fighting cost pressure from larger rivals, and a pending acquisition that could reshape its financial profile entirely. How regulators view the combination, and whether Iridium's subscriber base keeps growing, will shape how the market prices Rocket Lab stock well before the transaction is finalized.